Tolerability of sorafenib in the treatment of hepatocellular carcinoma (HCC) in patients with Child A and B liver cirrhosis

被引：0
|
作者：
Schuette, K.
Zimmermann, L.
Bornschein, J.
Huster, D.
Csepregi, A.
Malfertheiner, P.
机构：
[1] Univ Magdeburg, D-39106 Magdeburg, Germany
[2] Hufeland Klinikum, Bad Langensalza, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15593
引用
收藏
页数：2
相关论文
共 50 条
  • [1] COMPARISON OF SORAFENIB RESULTS IN THE TREATMENT OF INTERMEDIARY-ADVANCED OR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CHILD A AND B CIRRHOSIS
    Alves, Rogerio
    Alves, Daniele E.
    Harriz, Michelle C.
    Viana, Monica V.
    Chagas, Aline
    Linhares, Livia M.
    Brandalise, Renata
    Costa, Daniel P.
    Gampell, Otavio
    Poletti, Paula B.
    HEPATOLOGY, 2011, 54 : 1406A - 1407A
  • [2] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
    Alves, Rogerio C.
    Alves, Daniele E.
    Guz, Betty
    Viana, Monica V.
    Harriz, Michelle C.
    Matos, Carla A.
    Terrabuio, Deborah
    Chagas, Aline
    Moutinho, Renata D.
    Taddeo, Eliane F.
    Duarte, Kelly C.
    Oliveira, George P.
    Ribeirol, Juliana M.
    Kondo, Mario
    Gampel, Otavio
    Poletti, Paula
    HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
  • [3] Tolerability of Single-Agent Sorafenib in the Treatment of Elderly Patients With Hepatocellular Carcinoma (HCC)
    Francini, Edoardo
    Bianco, Vincenzo
    HEPATOLOGY, 2014, 60 (02) : 764 - 765
  • [4] HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH LIVER CIRRHOSIS
    Resuli, B.
    Babameto, A.
    Basho, J.
    Shehu, K.
    Akshia, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 113 - 113
  • [5] Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?
    Abou-Alfa, G. K.
    Amadori, D.
    Santoro, A.
    Figer, A.
    De Greve, J.
    Lathia, C.
    Voliotis, D.
    Anderson, S.
    Moscovici, M.
    Ricci, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] The liver enzymes in patients with cirrhosis and hepatocellular carcinoma (HCC)
    Serdarevic, N.
    Frankovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S155 - S155
  • [7] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
    Feun, L. G.
    Levi, D.
    Moon, J.
    Nishida, S.
    Island, E.
    Selvaggi, G.
    Martin, P.
    Savaraj, N.
    Mendes, F.
    Tzakis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis
    Chiu, Joanne
    Tang, Yuen Fong
    Yao, Tzy-Jyun
    Wong, Ashley
    Wong, Hilda
    Leung, Roland
    Chan, Pierre
    Cheung, Tan To
    Chan, Albert C.
    Pang, Roberta
    Fan, Sheung-Tat
    Poon, Ronnie
    Yau, Thomas
    CANCER, 2012, 118 (21) : 5293 - 5301
  • [9] Sorafenib for Patients with Hepatocellular Carcinoma and Child-Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study
    Labeur, Tim A.
    Achterbergh, Roos
    Takkenberg, Bart
    Van Delden, Otto
    Mathot, Ron
    Klumpen, Heinz-Josef
    ONCOLOGIST, 2020, 25 (09): : E1274 - E1279
  • [10] The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis.
    Chiu, J.
    Tang, Y. F.
    Yao, T. J.
    Wong, A.
    Wong, H.
    Leung, R. C.
    Chan, P.
    Cheung, T. T.
    Poon, R. T. P.
    Fan, S. T.
    Yau, C. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345